GS
Goldman Sachs Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
351
Roblox
RBLX
$91.4B
|
ES
Eric Sheridan
| $131.79 | $80 |
39%
downside
| Neutral |
14 May ‘25
3 months ago |
|
352
Olema Pharmaceuticals
OLMA
$511M
|
RL
Richard Law
| $7.44 | $18 |
142%
upside
| Buy |
14 May ‘25
3 months ago |
|
353
Mercado Libre
MELI
$120B
|
IS
Irma Sgarz
| $2,373.01 | $3,000 |
26%
upside
| Buy |
14 May ‘25
3 months ago |
|
354
KRONOS Worldwide
KRO
$724M
|
DF
Duffy Fischer
| $6.29 | $8.50 |
35%
upside
| Sell |
14 May ‘25
3 months ago |
|
355
iHeartMedia
IHRT
$339M
|
SL
Stephen Laws
| $2.26 | $1.25 |
45%
downside
| Neutral |
14 May ‘25
3 months ago |
|
356
Fortrea Holdings
FTRE
$914M
|
MS
Matthew Sykes
| $10.07 | $5 |
50%
downside
| Neutral |
14 May ‘25
3 months ago |
|
357
Chemours
CC
$2.5B
|
DF
Duffy Fischer
| $16.67 | $14 |
16%
downside
| Neutral |
14 May ‘25
3 months ago |
|
358
Axon Enterprise
AXON
$57.5B
|
MN
Michael Ng
| $731.98 | $830 |
13%
upside
| Buy |
14 May ‘25
3 months ago |
|
359
Axalta
AXTA
$6.8B
|
DF
Duffy Fischer
| $31.41 | $40 |
27%
upside
| Buy |
14 May ‘25
3 months ago |
|
360
Valero Energy
VLO
$50.3B
|
NM
Neil Mehta
| $161.83 | $154 |
5%
downside
| Buy |
13 May ‘25
3 months ago |
|
361
Aon
AON
$79B
|
RC
Robert Cox
| $366.38 | $408 |
11%
upside
| Buy |
13 May ‘25
3 months ago |
|
362
Brown & Brown
BRO
$30.8B
|
RC
Robert Cox
| $93.47 | $119 |
27%
upside
| Neutral |
13 May ‘25
3 months ago |
|
363
Ryan Specialty Holdings
RYAN
$6.74B
|
RC
Robert Cox
| $52.62 | $81 |
54%
upside
| Buy |
13 May ‘25
3 months ago |
|
364
TKO Group
TKO
$16.1B
|
SL
Stephen Laszczyk
| $196.43 | $188 |
4%
downside
| Buy |
12 May ‘25
4 months ago |
|
365
Rocket Lab Corporation Common Stock
RKLB
$22.7B
|
NP
Noah Poponak
| $47.03 | $16 |
66%
downside
| Neutral |
12 May ‘25
4 months ago |
|
366
PAR Technology
PAR
$1.9B
|
WN
Will Nance
| $46.86 | $65 |
39%
upside
| Neutral |
12 May ‘25
4 months ago |
|
367
OPAL Fuels
OPAL
$61.5M
|
AB
Adam Bubes
| $2.12 | $2 |
6%
downside
| Sell |
12 May ‘25
4 months ago |
|
368
Iovance Biotherapeutics
IOVA
$858M
|
AT
Andrea Tan
| $2.37 | $8 |
238%
upside
| Buy |
12 May ‘25
4 months ago |
|
369
Groupon
GRPN
$930M
|
ES
Eric Sheridan
| $23 | $15 |
35%
downside
| Sell |
12 May ‘25
4 months ago |
|
370
Grindr
GRND
$3B
|
ES
Eric Sheridan
| $15.64 | $26 |
66%
upside
| Buy |
12 May ‘25
4 months ago |
|
371
Definitive Healthcare
DH
$431M
|
KR
Kash Rangan
| $4.14 | $3.40 |
18%
downside
| Neutral |
12 May ‘25
4 months ago |
|
372
Cytek Biosciences
CTKB
$500M
|
MS
Matthew Sykes
| $3.93 | $3 |
24%
downside
| Sell |
12 May ‘25
4 months ago |
|
373
Cleveland-Cliffs
CLF
$5.35B
|
MH
Mike Harris
| $10.81 | $11.25 |
4%
upside
| Buy |
12 May ‘25
4 months ago |
|
374
Blend Labs
BLND
$1.1B
|
MN
Michael Ng
| $4.23 | $4.80 |
13%
upside
| Buy |
12 May ‘25
4 months ago |
|
375
AvePoint
AVPT
$3.52B
|
GB
Gabriela Borges
| $16.61 | $17 |
2%
upside
| Neutral |
12 May ‘25
4 months ago |
|